TY  - JOUR
A1  - Rebs, Sabine
A1  - Streckfuss-Bömeke, Katrin
T1  - How can we use stem cell-derived cardiomyocytes to understand the involvement of energetic metabolism in alterations of cardiac function?
JF  - Frontiers in Molecular Medicine
N2  - Mutations in the mitochondrial-DNA or mitochondria related nuclear-encoded-DNA lead to various multisystemic disorders collectively termed mitochondrial diseases. One in three cases of mitochondrial disease affects the heart muscle, which is called mitochondrial cardiomyopathy (MCM) and is associated with hypertrophic, dilated, and noncompact cardiomyopathy. The heart is an organ with high energy demand, and mitochondria occupy 30%–40% of its cardiomyocyte-cell volume. Mitochondrial dysfunction leads to energy depletion and has detrimental effects on cardiac performance. However, disease development and progression in the context of mitochondrial and nuclear DNA mutations, remains incompletely understood. The system of induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CM) is an excellent platform to study MCM since the unique genetic identity to their donors enables a robust recapitulation of the predicted phenotypes in a dish on a patient-specific level. Here, we focus on recent insights into MCM studied by patient-specific iPSC-CM and further discuss research gaps and advances in metabolic maturation of iPSC-CM, which is crucial for the study of mitochondrial dysfunction and to develop novel therapeutic strategies.
KW  - mitochondrial cardiomyopathy
KW  - iPSC-cardiomyocytes
KW  - maturation strategies
KW  - Barth syndrome
KW  - Friedreich’s ataxia
KW  - lysosomal storage disorders
Y1  - 2023
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-327344
VL  - 3
ER  - 
TY  - INPR
A1  - Brenner, Marian
A1  - Zink, Christoph
A1  - Witzinger, Linda
A1  - Keller, Angelika
A1  - Hadamek, Kerstin
A1  - Bothe, Sebastian
A1  - Neuenschwander, Martin
A1  - Villmann, Carmen
A1  - von Kries, Jens Peter
A1  - Schindelin, Hermann
A1  - Jeanclos, Elisabeth
A1  - Gohla, Antje
T1  - 7,8-Dihydroxyflavone is a direct inhibitor of pyridoxal phosphatase
T2  - eLife
N2  - Vitamin B6 deficiency has been linked to cognitive impairment in human brain disorders for decades. Still, the molecular mechanisms linking vitamin B6 to these pathologies remain poorly understood, and whether vitamin B6 supplementation improves cognition is unclear as well. Pyridoxal phosphatase (PDXP), an enzyme that controls levels of pyridoxal 5’-phosphate (PLP), the co-enzymatically active form of vitamin B6, may represent an alternative therapeutic entry point into vitamin B6-associated pathologies. However, pharmacological PDXP inhibitors to test this concept are lacking. We now identify a PDXP and age-dependent decline of PLP levels in the murine hippocampus that provides a rationale for the development of PDXP inhibitors. Using a combination of small molecule screening, protein crystallography and biolayer interferometry, we discover and analyze 7,8-dihydroxyflavone (7,8-DHF) as a direct and potent PDXP inhibitor. 7,8-DHF binds and reversibly inhibits PDXP with low micromolar affinity and sub-micromolar potency. In mouse hippocampal neurons, 7,8-DHF increases PLP in a PDXP-dependent manner. These findings validate PDXP as a druggable target. Of note, 7,8-DHF is a well-studied molecule in brain disorder models, although its mechanism of action is actively debated. Our discovery of 7,8-DHF as a PDXP inhibitor offers novel mechanistic insights into the controversy surrounding 7,8-DHF-mediated effects in the brain.
KW  - 7,8-dihydroxyflavone (7,8-DHF)
KW  - pyridoxal phosphatase (PDXP)
KW  - vitamin B6
KW  - PDXP inhibitors
Y1  - 2024
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-350446
ER  - 
TY  - JOUR
A1  - Hartmann, Nico
A1  - Knierim, Maria
A1  - Maurer, Wiebke
A1  - Dybkova, Nataliya
A1  - Hasenfuß, Gerd
A1  - Sossalla, Samuel
A1  - Streckfuss-Bömeke, Katrin
T1  - Molecular and functional relevance of Na\(_V\)1.8-induced atrial arrhythmogenic triggers in a human SCN10A knock-out stem cell model
JF  - International Journal of Molecular Sciences
N2  - In heart failure and atrial fibrillation, a persistent Na\(^+\) current (I\(_{NaL}\)) exerts detrimental effects on cellular electrophysiology and can induce arrhythmias. We have recently shown that Na\(_V\)1.8 contributes to arrhythmogenesis by inducing a I\(_{NaL}\). Genome-wide association studies indicate that mutations in the SCN10A gene (Na\(_V\)1.8) are associated with increased risk for arrhythmias, Brugada syndrome, and sudden cardiac death. However, the mediation of these Na\(_V\)1.8-related effects, whether through cardiac ganglia or cardiomyocytes, is still a subject of controversial discussion. We used CRISPR/Cas9 technology to generate homozygous atrial SCN10A-KO-iPSC-CMs. Ruptured-patch whole-cell patch-clamp was used to measure the I\(_{NaL}\) and action potential duration. Ca\(^{2+}\) measurements (Fluo 4-AM) were performed to analyze proarrhythmogenic diastolic SR Ca\(^{2+}\) leak. The I\(_{NaL}\) was significantly reduced in atrial SCN10A KO CMs as well as after specific pharmacological inhibition of Na\(_V\)1.8. No effects on atrial APD\(_{90}\) were detected in any groups. Both SCN10A KO and specific blockers of Na\(_V\)1.8 led to decreased Ca\(^{2+}\) spark frequency and a significant reduction of arrhythmogenic Ca\(^{2+}\) waves. Our experiments demonstrate that Na\(_V\)1.8 contributes to I\(_{NaL}\) formation in human atrial CMs and that Na\(_V\)1.8 inhibition modulates proarrhythmogenic triggers in human atrial CMs and therefore Na\(_V\)1.8 could be a new target for antiarrhythmic strategies.
KW  - Na\(_V\)1.8
KW  - iPSC-cardiomyocytes
KW  - late Na\(^+\) current (I\(_{NaL}\))
KW  - CRISPR Cas9
Y1  - 2023
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-362708
SN  - 1422-0067
VL  - 24
IS  - 12
ER  - 
TY  - JOUR
A1  - Harnoš, Jakub
A1  - Cañizal, Maria Consuelo Alonso
A1  - Jurásek, Miroslav
A1  - Kumar, Jitender
A1  - Holler, Cornelia
A1  - Schambony, Alexandra
A1  - Hanáková, Kateřina
A1  - Bernatík, Ondřej
A1  - Zdráhal, Zbynêk
A1  - Gömöryová, Kristína
A1  - Gybeľ, Tomáš
A1  - Radaszkiewicz, Tomasz Witold
A1  - Kravec, Marek
A1  - Trantírek, Lukáš
A1  - Ryneš, Jan
A1  - Dave, Zankruti
A1  - Fernández-Llamazares, Ana Iris
A1  - Vácha, Robert
A1  - Tripsianes, Konstantinos
A1  - Hoffmann, Carsten
A1  - Bryja, Vítězslav
T1  - Dishevelled-3 conformation dynamics analyzed by FRET-based biosensors reveals a key role of casein kinase 1
JF  - Nature Communications
N2  - Dishevelled (DVL) is the key component of the Wnt signaling pathway. Currently, DVL conformational dynamics under native conditions is unknown. To overcome this limitation, we develop the Fluorescein Arsenical Hairpin Binder- (FlAsH-) based FRET in vivo approach to study DVL conformation in living cells. Using this single-cell FRET approach, we demonstrate that (i) Wnt ligands induce open DVL conformation, (ii) DVL variants that are predominantly open, show more even subcellular localization and more efficient membrane recruitment by Frizzled (FZD) and (iii) Casein kinase 1 ɛ (CK1ɛ) has a key regulatory function in DVL conformational dynamics. In silico modeling and in vitro biophysical methods explain how CK1ɛ-specific phosphorylation events control DVL conformations via modulation of the PDZ domain and its interaction with DVL C-terminus. In summary, our study describes an experimental tool for DVL conformational sampling in living cells and elucidates the essential regulatory role of CK1ɛ in DVL conformational dynamics.
KW  - biological techniques
KW  - cell signalling
KW  - phosphorylation
Y1  - 2019
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-227837
VL  - 10
ER  -